Latest news
Saab Australia delivers JP2060 Phase 3 - Australian Defence MagazineAustralian Defence Magazine · Fri, 07 Aug 2026 04:48:05 GMTForlong advances IL-15 superagonist into Australian Phase I trial with subcutaneous dosing - AllSciAllSci · Wed, 05 Aug 2026 10:31:21 GMTForlong Biotechnology Announces Approval to Initiate Phase I Clinical Trial of FL115 (IL-15 Superagonist) Subcutaneous Injection in Australia - BioSpaceBioSpace · Wed, 05 Aug 2026 03:09:14 GMTArkBio completes cohort dosing in Australian Phase I trial of influenza candidate AK0406 - BioSpectrum AsiaBioSpectrum Asia · Tue, 04 Aug 2026 12:00:00 GMT